Cigarette smoking and inflammatory skin disease. The good and the bad.
Smith
J B
JB
Smith
S B
SB
D000279:Administration, Cutaneous; D000697:Central Nervous System Stimulants / Q000008:administration & dosage; D003872:Dermatitis / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D018722:Nicotinic Agonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011109:Polymethacrylic Acids / Q000008:administration & dosage; D011145:Polyvinyls / Q000008:administration & dosage; D012867:Skin / Q000187:drug effects / Q000503:physiopathology; D012907:Smoking / Q000009:adverse effects*; D061485:Tobacco Use Cessation Devices
D000697:Central Nervous System Stimulants; D018722:Nicotinic Agonists; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine